| Mrs Celeste Dubois, RPH | |
|
101 Page St, New Bedford, MA 02740-3464 | |
| (508) 997-1515 | |
| Not Available |
| Full Name | Mrs Celeste Dubois |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 101 Page St, New Bedford, Massachusetts |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033303037 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 23604 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Celeste Dubois, RPH 55 Michael Dr, Bristol, RI 02809-4550 Ph: (978) 853-0464 | Mrs Celeste Dubois, RPH 101 Page St, New Bedford, MA 02740-3464 Ph: (508) 997-1515 |
News Archive
Veterans with substance use disorders who die by suicide are more likely to use violent means (such as a firearm) rather than nonviolent means (such as a drug overdose), new research suggests.
Although "[h]ealth insurers insist they're still committed to getting a health care overhaul bill passed this year," many people in Washington are "wondering if — or when — the industry will change its mind and try to kill it," The Associated Press reports.
Dyadic International, Inc., a leading biotechnology company focused on the development and manufacture of bioproducts based on its cutting-edge C1 technology to address the needs of multi-billion dollar markets for biofuels, biotherapeutics and industrial enzymes, announced today that it has signed a non-binding term sheet with EnGen Bio, Inc. for a potential outlicense, on an exclusive worldwide basis, of Dyadic's C1 platform technology for applications in biopharmaceutical drug development.
Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced that data from an interim analysis of its INSPIRE Phase I/IIa study of HIV-infected patients with low CD4 T cell counts treated with a three injection cycle of the Company's investigative immune-modulator, recombinant human Interleukin-7 (CYT107), will be presented during an oral late breaker session at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), to be held September 12-15, 2009, in San Francisco, CA.
› Verified 9 days ago
Kyle Emanuel Roque, DR Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1103 Kempton St, New Bedford, MA 02740 Phone: 508-990-3765 | |
Mrs. Ana Claudia Dacunha-cole, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2170 Acushnet Ave, New Bedford, MA 02745 Phone: 508-995-6408 | |
Stefani Lynne Mcmillian, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 824 Purchase St, New Bedford, MA 02740 Phone: 508-992-2422 | |
Dr. Rosary Marie Demello, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2100 Acushnet Ave, New Bedford, MA 02745 Phone: 508-995-2653 | |
Benjamin Taylor, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 838 Pleasant St, New Bedford, MA 02740 Phone: 508-984-4434 | |
Amy Lynn Solomon, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1103 Kempton St, New Bedford, MA 02740 Phone: 508-643-2007 Fax: 508-990-7780 |